US FDA finalizes guidance on standardized labelling of Rx drugs, biologics
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has at last finalized its guidance on the labeling of prescription drug and biologic products to ensure that labels are clear, useful, informative and, as far as possible, consistent in content and format1,2.